GE HealthCare Management to Present at 42nd Annual J.P. Morgan Healthcare Conference

CHICAGO–(BUSINESS WIRE)–GE HealthCare (Nasdaq: GEHC) is announcing today that President and Chief Executive Officer, Peter Arduini, and Vice President and Chief Financial Officer, Jay Saccaro, will attend the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9th in San Francisco. Both GE HealthCare executives will participate in a Q&A session following Arduini’s presentation at 2:15 pm ET/11:15 am PT.

This live webcast can be accessed by visiting GE HealthCare’s Investor Relations website here https://investor.gehealthcare.com/news-events/events, where it will also be archived.

About GE HealthCare Technologies Inc.

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are an $18.3 billion business with 50,000 employees working to create a world where healthcare has no limits.

Follow us on LinkedIn, Twitter, and Insights for the latest news, or visit our website gehealthcare.com for more information.

Contacts

Investor Relations Contact:
Carolynne Borders

+1-631-662-4317

carolynne.borders@gehealthcare.com

Media Contact:
Tor Constantino

+1-585-441-1658

tor.constantino@gehealthcare.com

Staff

Recent Posts

Cardiol Therapeutics Reports Results of 2024 Annual General and Special Meeting of Shareholders

Toronto, Ontario--(Newsfile Corp. - June 27, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL)…

1 hour ago

Neural Therapeutics Announces Changes to Board of Directors and Advisors

Toronto, Ontario--(Newsfile Corp. - June 27, 2024) - Neural Therapeutics Inc. ("Neural" or the "Company"),…

2 hours ago

cbdMD Announces Publication of Human Clinical Trial Data

Charlotte, North Carolina--(Newsfile Corp. - June 27, 2024) -  cbdMD, Inc. (NYSE American: YCBD) (NYSE…

2 hours ago

Newsweek Names Help at Home as One of America’s Greatest Workplaces 2024

Ranking includes factors such as diversity, culture, work-life balance, career opportunities CHICAGO, June 27, 2024…

2 hours ago

South Dakota Partners with Trualta to Support Family Caregivers

All caregivers in the state can access free resources at home PIERRE, S.D., June 27,…

2 hours ago

Lucius Partners Portfolio Company Algorithm Sciences, Inc. Closes on the Creation of a Majority Owned Subsidiary – Infusyn Therapeutics

Infusyn Therapeutics will manufacture and supply the Prometra II pump currently serving the Pain and…

2 hours ago